AbbeyMoor Medical
Fifty percent of men at age 50 experience some urinary dysfunction [1], increasing to over ninety percent at age 80. Disease states include incontinence, erectile dysfuntion, prostate cancer, prostatitis, enlarged prostate, and urinary retention. Even when these problems may not be life-threatening, they can be totally disruptive to a man’s quality of life.
The founders of AbbeyMoor Medical believed they could bring innovation to the needs of these men. Founded in 1996, The Company includes some of the most creative mechanical engineers in medical device technology. With state of the art laboratories and a Class 100,000 clean room, AbbeyMoor is focused on the development of products to improve male urinary health.
Privately held, AbbeyMoor has been the recipient of angel-funding since its inception. And conducting good science has been its goal. Currently holding 13 U.S. patents, with 8 under review, and 12 patents pending internationally, intellectual property is the cornerstone of The Company. Their first product, The Spanner™ temporary stent for the prostate, is designed for men with urinary voiding dysfunction due to an obstructed prostate. With The Spanner successfully brought to market, The Company has the development of other devices underway for the assessment, management, and treatment of male lower urinary tract symptoms.
The employees of AbbeyMoor Medical believe that men suffering retention deserve better than catheterization. Men suffering incontinence deserve better than a pad. Men experiencing systemic side effects to oral prostate medications deserve an alternative. And urologists puzzled by the etiology of a man’s urinary symptoms deserve better diagnostic tools. Working with physicians and patients alike, AbbeyMoor is uniquely poised to develop innovative products for men suffering LUTS.
To help us with our effort, please feel free to contact us for further information.
[1] Source: Benign Prostatic Hyperplasia: Antecedents and Natural History. Guess Epidemiol Rev.1992;
